Nathan Peiffer-Smadja

InstitutionBichat Claude Bernard Hospital
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 26 Covid-19 publications, with a maximum of 6 publications in November 2020
    All Publications
    Bar chart showing 37 publications over 6 distinct years, with a maximum of 17 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Peiffer-Smadja N, Bridier-Nahmias A, Ferré VM, Charpentier C, Garé M, Rioux C, Allemand A, Lavallée P, Ghosn J, Kramer L, Descamps D, Yazdanpanah Y, Visseaux B. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2. Viruses. 2021 08 19; 13(8). PMID: 34452507.
      Citations: 3     Fields:    Translation:Humans
    2. Besançon L, Peiffer-Smadja N, Segalas C, Jiang H, Masuzzo P, Smout C, Billy E, Deforet M, Leyrat C. Open science saves lives: lessons from the COVID-19 pandemic. BMC Med Res Methodol. 2021 06 05; 21(1):117. PMID: 34090351.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    3. Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837. PMID: 34048876.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    4. Ridde V, Gautier L, Dagenais C, Chabrol F, Hou R, Bonnet E, David PM, Cloos P, Duhoux A, Lucet JC, Traverson L, de Araujo Oliveira SR, Cazarin G, Peiffer-Smadja N, Touré L, Coulibaly A, Honda A, Noda S, Tamura T, Baba H, Kodoi H, Zinszer K. Learning from public health and hospital resilience to the SARS-CoV-2 pandemic: protocol for a multiple case study (Brazil, Canada, China, France, Japan, and Mali). Health Res Policy Syst. 2021 May 06; 19(1):76. PMID: 33957954.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Deschanvres C, Haudebourg T, Peiffer-Smadja N, Blanckaert K, Boutoille D, Lucet JC, Birgand G. How do the general population behave with facemasks to prevent COVID-19 in the community? A multi-site observational study. Antimicrob Resist Infect Control. 2021 03 29; 10(1):61. PMID: 33781341.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Peiffer-Smadja N, Rozencwajg S, Kherabi Y, Yazdanpanah Y, Montravers P. COVID-19 vaccines: A race against time. Anaesth Crit Care Pain Med. 2021 04; 40(2):100848. PMID: 33774261.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    7. Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S. Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998]. Clin Microbiol Infect. 2021 Mar; 27(3):499. PMID: 33540115.
      Citations: 1     Fields:    
    8. Bouiller K, Catho G, Le Maréchal M, Gras J, Hentzien M, Peiffer-Smadja N, Bessis S, Cabon M, Dubee V, Lemaignen A, Thy M, Martins C, Thill P, Osei L. The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey. Infect Dis Now. 2021 Mar; 51(2):215-217. PMID: 33495762.
      Citations:    
    9. Lê MP, Peiffer-Smadja N, Guedj J, Neant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. J Antimicrob Chemother. 2021 01 01; 76(1):277-279. PMID: 33089306.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    10. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris). 2021 Jan-Feb; 177(1-2):51-64. PMID: 33446327.
      Citations: 14     Fields:    Translation:HumansCells
    11. Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC. Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings. JAMA Netw Open. 2020 12 01; 3(12):e2033232. PMID: 33355679.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    12. Belaroussi Y, Roblot P, Peiffer-Smadja N, Delaye T, Mathoulin-Pelissier S, Lemeux J, Le Moal G, Caumes E, Roblot F, Bleibtreu A. Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? J Clin Med. 2020 Nov 17; 9(11). PMID: 33213035.
      Citations:    
    13. Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2021 Mar; 27(3):458-466. PMID: 33189873.
      Citations: 19     Fields:    Translation:Humans
    14. Peiffer-Smadja N, Rebeaud ME, Guihur A, Mahamat-Saleh Y, Fiolet T. Hydroxychloroquine and COVID-19: a tale of populism and obscurantism. Lancet Infect Dis. 2021 05; 21(5):e121. PMID: 33197384.
      Citations: 3     Fields:    Translation:Humans
    15. Peiffer-Smadja N, Yazdanpanah Y. Nebulised interferon beta-1a for patients with COVID-19. Lancet Respir Med. 2021 02; 9(2):122-123. PMID: 33189160.
      Citations: 13     Fields:    Translation:Humans
    16. Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response. Clin Microbiol Infect. 2021 06; 27(6):920-921. PMID: 33166647.
      Citations: 3     Fields:    Translation:Humans
    17. Peiffer-Smadja N, Costagliola D. RE: "EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS". Am J Epidemiol. 2020 11 02; 189(11):1443-1444. PMID: 32685975.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    18. Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response. Clin Microbiol Infect. 2021 01; 27(1):138-140. PMID: 33080383.
      Citations: 4     Fields:    Translation:Humans
    19. Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 2020 Oct 13; 21(1):846. PMID: 33050924.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    20. Sallard E, Sallard E, Belhadi D, Lescure FX, Yazdanpanah Y, Peiffer-Smadja N. Clinical trial protocols of repurposed prophylaxis for COVID-19: A review. Infect Dis Now. 2021 02; 51(1):7-13. PMID: 33022293.
      Citations: 2     Translation:HumansPHPublic Health
    21. Lê MP, Peiffer-Smadja N, Guedj J, Néant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020 09 01; 75(9):2376-2380. PMID: 32473020.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    22. Peiffer-Smadja N, Lescure FX, Sallard E, Ravaud P, Vegreville B, Zeitoun JD. Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19. J Antimicrob Chemother. 2020 09 01; 75(9):2708-2710. PMID: 32514563.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    23. Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Jan; 27(1):19-27. PMID: 32860962.
      Citations: 88     Fields:    Translation:Humans
    24. Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S. Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect. 2020 Aug; 26(8):988-998. PMID: 32454187.
      Citations: 38     Fields:    Translation:HumansCellsPHPublic Health
    25. Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C, Jacques S, Khalil A, Maisani P, Casalino E, Descamps D, Descamps D, Timsit JF, Yazdanpanah Y, Lescure FX. Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre. Clin Microbiol Infect. 2020 Jun; 26(6):669-672. PMID: 32278082.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    26. Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020 06; 178:104791. PMID: 32275914.
      Citations: 193     Fields:    Translation:HumansCellsPHPublic Health
    Peiffer-Smadja's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (151)
    Explore
    _
    Co-Authors (209)
    Explore
    _
    Similar People (60)
    Explore
    _